This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (110)  • Contact me when this article is cited  Related Content  • Related article  • Similar articles in JAMA  Topic Collections  • Drug Therapy  • Adverse Effects  • Alert me on articles by topic  Social Bookmarking   What's this?

Arthur J. Barsky, MD; Ralph Saintfort, MD; Malcolm P. Rogers, MD; Jonathan F. Borus, MD

JAMA. 2002;287:622-627.

Patients taking active medications frequently experience adverse, nonspecific side effects that are not a direct result of the specific pharmacological action of the drug. Although this phenomenon is common, distressing, and costly, it is rarely studied and poorly understood. The nocebo phenomenon, in which placebos produce adverse side effects, offers some insight into nonspecific side effect reporting. We performed a focused review of the literature, which identified several factors that appear to be associated with the nocebo phenomenon and/or reporting of nonspecific side effects while taking active medication: the patient's expectations of adverse effects at the outset of treatment; a process of conditioning in which the patient learns from prior experiences to associate medication-taking with somatic symptoms; certain psychological characteristics such as anxiety, depression, and the tendency to somatize; and situational and contextual factors. Physicians and other health care personnel can attempt to ameliorate nonspecific side effects to active medications by identifying in advance those patients most at risk for developing them and by using a collaborative relationship with the patient to explain and help the patient to understand and tolerate these bothersome but nonharmful symptoms.

Author Affiliations: Department of Psychiatry, Brigham and Women's Hospital and Harvard Medical School, Boston, Mass.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

RELATED ARTICLE

February 6, 2002
JAMA. 2002;287(5):655-656.
EXTRACT | FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

A Functional Magnetic Resonance Imaging Study on the Neural Mechanisms of Hyperalgesic Nocebo Effect
Kong et al.
J. Neurosci. 2008;28:13354-13362.
ABSTRACT | FULL TEXT  

Placebo effects: clinical aspects and neurobiology
Oken
Brain 2008;131:2812-2823.
ABSTRACT | FULL TEXT  

The thinking doctor's guide to placebos
Pittrof and Rubenstein
BMJ 2008;336:1020-1020.
FULL TEXT  

Nationwide Survey of Subjectively Reported Adverse Drug Reactions in Sweden
Isacson et al.
The Annals of Pharmacotherapy 2008;42:347-353.
ABSTRACT | FULL TEXT  

American Osteopathic Association's Position Against Use of Placebos for Pain Management in End-of-Life Care
Council on Palliative Care Issues
JAOA: Journal of the American Osteopathic Association 2007;107:ES35-ES38.
ABSTRACT | FULL TEXT  

Placebo and Nocebo in Cardiovascular Health: Implications for Healthcare, Research, and the Doctor-Patient Relationship
Olshansky
J Am Coll Cardiol 2007;49:415-421.
ABSTRACT | FULL TEXT  

Are some people sensitive to mobile phone signals? Within participants double blind randomised provocation study
Rubin et al.
BMJ 2006;332:886-891.
ABSTRACT | FULL TEXT  

Role of Pharmacist Counseling in Preventing Adverse Drug Events After Hospitalization.
Schnipper et al.
Arch Intern Med 2006;166:565-571.
ABSTRACT | FULL TEXT  

Medication-Attributed Adverse Effects in Placebo Groups: Implications for Assessment of Adverse Effects
Rief et al.
Arch Intern Med 2006;166:155-160.
ABSTRACT | FULL TEXT  

Dealing With a Deluge of Data: An Assessment of Adverse Event Data on North Central Cancer Treatment Group Trials
Mahoney et al.
JCO 2005;23:9275-9281.
ABSTRACT | FULL TEXT  

Neurobiological Mechanisms of the Placebo Effect
Benedetti et al.
J. Neurosci. 2005;25:10390-10402.
FULL TEXT  

The Placebo Response in the Treatment of Chronic Fatigue Syndrome: A Systematic Review and Meta-Analysis
Cho et al.
Psychosom. Med. 2005;67:301-313.
ABSTRACT | FULL TEXT  

AOA's Position Against Use of Placebos for Pain Management in End-of-Life Care
Nichols et al.
JAOA: Journal of the American Osteopathic Association 2005;105:2S-5S.
ABSTRACT | FULL TEXT  

Keratinocyte Growth Factor: Not Yet Ready for Prime Time
Loprinzi and Martenson
JCO 2003;21:1429-1430.
FULL TEXT  

Review: {beta} blockers increase fatigue and sexual dysfunction but not depression after myocardial infarction * In response
Ko et al.
Evid. Based Med. 2003;8:40-40.
FULL TEXT  

Review: {beta} blockers increase fatigue and sexual dysfunction but not depression after myocardial infarction
Swann
Evid. Based Med. 2003;8:15-15.
FULL TEXT  

When Are Medication Side Effects Due to the Nocebo Phenomenon?
Palmer et al.
JAMA 2002;287:2502-2504.
FULL TEXT